Open Access

Renin-angiotensin-aldosterone system inhibitor therapy benefit and challenges in cardio-renal patients.

Congress Presentation

About the speaker

Professor Matthew Weir

Baltimore (United States of America)
2 presentations
0 follower

4 more presentations in this session

Introduction - Enabling and renin-angiotensin-aldosterone system inhibitor therapy in cardio-renal patients through hyperkalaemia management.

Speaker: Professor M. Boehm (Homburg, DE)

Thumbnail

Changing the treatment paradigm of hyperkalaemia management to enable and optimise renin-angiotensin-aldosterone system inhibitor therapy.

Speaker: Professor S. Anker (Berlin, DE)

Thumbnail

Panel discussion - Enabling and optimising renin-angiotensin-aldosterone system inhibitor therapy in cardio-renal patients through hyperkalaemia management.

Speaker: Professor M. Boehm (Homburg, DE)

Thumbnail

Summary and conclusion - Enabling and optimising renin-angiotensin-aldosterone system inhibitor therapy in cardio-renal patients through hyperkalaemia management.

Speaker: Professor M. Boehm (Homburg, DE)

Thumbnail

Access the full session

Enabling and optimising renin-angiotensin-aldosterone system inhibitor therapy in cardio-renal patients through hyperkalaemia management

Speakers: Professor M. Weir, Professor M. Boehm, Professor S. Anker, Professor M. Boehm, Professor M. Boehm
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb